- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Novavax launches trial of coronavirus vaccine candidate | ||
| Di | New US approval for Takeda's Alunbrig | ||
| Di | Sanofi to sell stake in Regeneron | ||
| Di | AstraZeneca links with ArcherDX to detect minimal residual disease in lung cancer patients | ||
| Sa | Gov't unveils coronavirus antibody testing scheme | ||
| Sa | Gov't invests £7m in patient recruitment centres for clinical research | ||
| Sa | GSK partners with Samsung to expand biopharma manufacturing | ||
| Sa | NICE u-turn backs Roche's Tecentriq for triple negative breast cancer | ||
| Do | Researchers investigate impact of lockdown on musculoskeletal conditions | ||
| Do | First UK healthcare worker to enrol in COVID-19 prevention trial | ||
| Do | UK risks second surge of coronavirus without clarity on test, track and trace | ||
| Do | AstraZeneca/MSD's Lynparza wins prostate cancer approval | ||
| 20.05. | Ergomed teams up with Automation Anywhere and DataRobot | ||
| 20.05. | New US nod for Roche's Tecentriq in NSCLC | ||
| 20.05. | Pharmacists should have greater powers to ensure meds access, says RPS | ||
| 20.05. | UK's coronavirus testing capacity has been 'inadequate', Committee finds | ||
| 18.05. | New COVID-10 guidelines for CKD and interstitial lung disease | ||
| 18.05. | ViiV HIV prevention trial stopped early on efficacy | ||
| 18.05. | AstraZeneca/Daiichi Sankyo's Enhertu picks up third breakthrough designation | ||
| 18.05. | Gov't streams £84m into UK COVID-19 vaccines research | ||
| 15.05. | Roche launches new blood gas digital solution | ||
| 15.05. | Exvastat wins 3.6m euro grant for COVID-19 trial | ||
| 15.05. | A&E visits hit lowest level on record | ||
| 15.05. | EU regulators approve Takeda's Adcetris for sALCL | ||
| 14.05. | FDA refuse to file BMS/bluebird bio's CAR-T therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
